Guardant Health welcomes Pennsylvania law expanding colorectal cancer screening coverage
GH•Pennsylvania's HB 1123 expands colorectal cancer screening coverage, including for Guardant Health's Shield blood test, without cost-sharing. The law covers about 2 million screening-eligible residents through state-regulated insurance plans and Medicaid, effective December 21, 2026.
1. Pennsylvania coverage expansion
Guardant Health welcomed Pennsylvania's HB 1123, which expands access to colorectal cancer screening options, including its Shield blood test, without cost-sharing. The law covers about 2 million screening-eligible Pennsylvanians through state-regulated insurance plans and Medicaid, effective December 21, 2026. Coverage will align with American Cancer Society and NCCN guidelines, which include Shield.
